Diagnostics

The Diagnostics market includes a range of diagnostics tests and devices that can detect diseases or measure different vital signs. These include in vitro diagnostics tests and lab-on-a-chip products that process a sample, such as blood or saliva to detect diseases or other conditions.

Other devices in this market are biosensors worn on the body that can measure vital signs such as heart rate and blood pressure or glucose levels to manage diabetes. Early diagnosis of diseases and conditions is critical as the medical industry moves to more personalized healthcare and faster treatment.

Microfluidic Solutions for Diagnostics

Resonetics is a market leader in microfluidic laminate manufacturing used to make point-of-care and lab-on-a-chip devices. Our combined expertise in roll-to-roll laser processing, mechanical die cutting, automated stacking, lamination, and reagent handling allows us to produce complete microfluidic products. Our processes use highly automated equipment that can quickly scale to high-volume production with limited tooling. This allows our processes to be fast and flexible, saving years in the time it takes to develop and commercialize a new device.

Diagnostic Manufacturing Capabilities

  • Roll-to-roll laser processing
  • Rotary and flatbed die cutting
  • Multi-layer laminating
  • Automated precision stacking
  • Reagent and antibody placement
  • High-density laser perforation
  • Packaging

Diagnostic Applications

  • Point-of-care testing
  • Biosensors
  • Continuous glucose monitoring
  • Patient monitoring
  • Molecular diagnostics
  • Infectious disease testing
  • Clinical chemistry
  • Immunoassays

See our Latest News

NEWS

January 27, 2026

Resonetics to Acquire Resolution Medical, Expanding Capabilities in Neuromodulation and Structural Heart Markets

Nashua, NH – January 27th, 2026 – Resonetics announced today that it has signed an agreement to acquire Resolution Medical,…

Read More

NEWS

January 6, 2026

Resonetics® Expands Bioelectronics Implant Offering with Acquisition of Manufacturing Assets and Process IP from Med-Ally

Nashua, NH – January 6th, 2026 – Resonetics® announced today that it has acquired the manufacturing assets, process know-how, and…

Read More

NEWS

September 29, 2025

Resonetics® Acquires Eden Holdings, Adding Injection Molding to its Capabilities

Acquisition adds precision micro-molding, insert molding, and advanced machining and tooling to Resonetics’ portfolio of precision manufacturing capabilities. Nashua, NH…

Read More